Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It oh Looks like the head clown woke up Probably had a meeting with the clown crew to get their talking points together Wonder why she is here lol
What does a straw hut go for these days? Split amongst 14 people?
This is old news...
We are looking at $100 per share...
My accounts are bustin' at the seams today !!
Is news coming Monday ????
I have heard that there are hedge fund managers selling their homes in The Hamptons and squatting in tents on public land, using the proceeds to buy shares that they believe are heading to ....... you believe it or not ........ $50.00 per share !!!!
I know I know, it's wild,
LoL LoL,
IB_🤴🏻
Me too … it’s Hammer Time It’s gonna get real I’m waiting for the sale of my residence so I can top off
I'm buying today ............
Nas🐀 could take this to $50.00 per share, right ?????????????
IB_🤴🏻
Charity begins at home
Start buying we will follow
No, The Board 🤡 just post about "Topping Off" and "Buying More" to have something to post !!!!!!!!
IB_🤴🏻
Well, we all know that is a joke, curtesy of The Board 🤡 !!!!!!!!!!!!!!
IB_🤴🏻
Yes and you have been doing it for the last 10 years It’s about to get real Hammer time I’m topping off lmao
50k A DAY IS THE BEST i CAN DO
Shortages:
ELTP buyers
Shortages:
FDA shortage link
for Adderall:
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet&st=c&tab=tabs-1
FDA shortage link for Vyvance
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c
FDA shortage link for Concerta
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release&st=c
FDA shortage link for Naltrexone
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Naltrexone%20Hydrochloride%20Tablet&st=c
FDA shortage link for Methotrexate
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methotrexate%20Sodium%20Tablet&st=c
BULLISH ELTP
Not even a half million shares have been traded today ....
Why isn't EVERYONE buying this $40.00 stock on sale for $0.12 (12 Cent) ????????
IB_🤴🏻
Info about Prasco - From CRUNCHBASE:
Growth Insight Details
Powered by AI
Prasco Laboratories may be growing as it is listed among key players in the bronchodilators market, which is projected to be worth $27.59 billion by 2030, indicating a significant market presence and potential revenue stream. Additionally, the company is mentioned in the context of the doxercalciferol market exploration, suggesting involvement in industry opportunities and challenges, which could imply active participation in market expansion and product development. The inclusion in these reports suggests that Prasco Laboratories is operating in growing market segments, which is often a positive indicator of a company's growth trajectory.
The last quarter included a shipment to Prasco. Carter called it out in the CC. So it will be second shipment. But our hope is that they ship to Prasco multiple times a quarter of the Dec shipment was smaller than typical.
Looks like July 2nd
When the Q4 revenue numbers comes out? Q4 will be first quarter with Prasco
Just got this message from my bank: Your order for ELTP placed on May 10, 2024 at 07:55 ET has been filled.
When will we have next conference call?
Not if Mikah owns it
Have you spoke with Nas🐀 lately ????????????????
IB_🤴🏻
I'm thinking we stay relatively flat. Maybe go up a few cents to the 0.15 or 0.16 range but not much more than that. The last quarters revenue increased only about 10% from the one prior. I think that made many investors think that Elite has reached their peak revenue until they put out another product. I'm hoping that idea is proven wrong, but I doubt there will be investor excitement prior to earnings being published.
Of course we did file the generic Oxy in early Aug so in theory the generic Oxy could be approved before the CC. That would be some news that blows things out of the waters. BTW, I don't expect that as I can't imagine the FDA won't have questions (as they do with everything). But on the other hand the oxy is an opioid product and Elite should know how to get those done by now.
I like the idea - we have about 35 days of trading until the next CC - and we may get some news addressing NASDAQ2020's list of Catalysts - that makes it really interesting.
Are you saying ELTP may be bought out within 3 years for $38.00 per share or more, Board 🤡 ?????????????
IB_🤴🏻
OK, new PPS game: we’re getting fairly close to the next conference call on earnings so let’s play guest. The PPS high anytime before that call!
I say we will hit at least at least .25 before that call or .30
CHARLES SCHWAB : The trade settlement period will be shortened to one day beginning May 28, 2024.
Starting on May 28, 2024, the settlement period for most securities traded on U.S. exchanges or over the counter will shorten from two business days (T+2) to one business day (T+1). For most investors, this event may have little or no impact.
ELTP
Yes that would be amazing, but don’t expect that sort of forward PE from a generic Rx company.
Whats 5-10% of $5.1 BILLION ??
Then add another $100 million in revenues
Thx for your DD
Pre-market action today - _IB bought some lol
Heck yeah, $38.00 stock, right ?????
IB_🤴
Imagine buying a stock that is worth $32.00 per share for $0.11+ cent……….
Would that not be amazing ????
IB_🤴
It’s hard to find a direct comparison to Elite due to the low debt structure, which is why an external valuation is in order sometime soon.
Hi Lazarus,
There were so few companies that had a P/E that it was unlikely to find another one exactly in Elite's space.
I found the Research tab of Schwab very useful by the way - we can find our next stocks pretty easily (I mean after the buyout) we can discuss that in Vegas when we meet as VIP's
I already put my eyes on some stocks that will preserve our wins. But for now - let's focus on going back up. Enough with taking the stock down to buy more - if 14 years was not enough to buy stock, then it just means you missed the train lol.
Let's bring this puppy back up where it deserves to be.
Thought it was a buyout at .25. Isn’t that what you said? By Mikah? Oscillating quite a bit there eh? Lol
Do you know why you are here?
🤣😂😆
Do you think you will cash out before ELTP hits $30.00 per share ???????????
IB_🤴🏻
$35.00 per share ???????????????????????????
Gooooo Nas🐀,
IB_🤴🏻
Awesome research btw. Thank you. Did you happen to see if they were generic or shooting a moon shot at an experimental drug? Best way to get a comp is to look at generics. Moonshots are somewhat understandable when they have a high PE because the goal is the 1 in a million that they get it approved.
I love ELTP, but we have to be realistic about who and what we are, so we may not get the same multiple as the aggregated list, but it's still cool to see. Ironically, though, our PE SHOULD be 35 right now, because our revenue is almost guaranteed to skyrocket. That's the REAL crazy thing. So many investors are shooting for a "what if" when this company is currently a "how could it not?". If they buy a moon shot that moons, part of their profits are already baked in to the price. If they buy ELTP, the clear 10x is clearly being undervalued.
Lol you think I'm Pharma? Sorely mistaken. The irony is you are doing what I am doing. Mocking the guys who clearly all work for the same boss and/or have multiple accounts.
If you are with the goats, I guess I should be blocking you as well. I only see their posts if I look through the replies of the non trolls. LMK if you need to get added.
Nm. You already told me who you are. Blocked.
Do you know why you are here?
Just thought I’d continue asking the same question as the person that has multiple IDs and only asks this question.
DANG!!! Imagine a 35 PE ratio at $500 million in revenue...
Do you even know why you are here?
I think Ihub is just as liable. They've been given constructive notice and could easily file a SAR or equivalent form. Not doing so seems like gross negligence to me.
Filthy rich ? No I think just filthy
That sounds like a generous job considering how often they comment. Probably adds 2 cents to their Christmas bonus
Followers
|
963
|
Posters
|
|
Posts (Today)
|
3
|
Posts (Total)
|
400699
|
Created
|
03/24/09
|
Type
|
Free
|
Moderators jimr1717 mrwrn2010 NASDAQ2020 IB_ namtae Dr JoeBarducci |
Elite needs a Board of Directors that represents all shareholders !!!
Senior Moderator: IB_
Posted: 6/5/23
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 53 | 55,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 389.8 M | On Market | 15 | Elite |
Adderall XR | 1.56 B | On Market | 10 | Elite & Prasco |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Vigabatrin | 233.7 M | On Market | 13 | Pyros |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 45 M | Approved (On Hold - Opioid) | 5 | ---------- |
Dopamine Agonist | 12 M | Filed with FDA - 22 Dec 2022 | ---------- | ---------- |
Methotrexate | 64.3M | Approved - 16 May 2024 | 8 | Elite |
OxyContin | 720 M | Filed with FDA - 17 Aug 2023 | ---------- | ---------- |
Vyvanse | 5.1 B | Filed with FDA - 21 Dec 2023 | 14 | ---------- |
Concerta | 1.16 B | In Development (Final Stages) | 9 | ---------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 Q1 | 8,980,076 | +17.04% | 1,141,809 | +273.28% |
2024 Q2 | 14,157,185 | +64.90% | 14,934,601 | +866.0% |
2024 Q3 | 15,538,800 | +68.00% | 3,500,000 | +80.0% |
FY 2024 Projected | Minimum Projected: 50,000,000 | Minimum YOY Projected Increase of 68.31% | ||
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |